Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.2 EUR
4.92 M EUR
17.34 M EUR
479.39 K
About MEVIS MEDICAL SOLUTIONS AG
Sector
Industry
CEO
Marcus Kirchhoff
Website
Headquarters
Bremen
Founded
1997
ISIN
DE000A0LBFE4
FIGI
BBG000TVDNR5
MeVis Medical Solutions AG engages in the provision of software for the analysis and processing of image data. It offers its solution to manufacturers of medical devices and medical information technology-platforms. The company was founded in 1997 and is headquartered in Bremen, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of M3V is 25.2 EUR — it has increased by 0.81% in the past 24 hours. Watch MEVIS MEDICAL SOLUTIONS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange MEVIS MEDICAL SOLUTIONS AG stocks are traded under the ticker M3V.
M3V stock has risen by 2.48% compared to the previous week, the month change is a 1.64% rise, over the last year MEVIS MEDICAL SOLUTIONS AG has showed a −5.26% decrease.
M3V stock is 1.59% volatile and has beta coefficient of −0.13. Track MEVIS MEDICAL SOLUTIONS AG stock price on the chart and check out the list of the most volatile stocks — is MEVIS MEDICAL SOLUTIONS AG there?
Today MEVIS MEDICAL SOLUTIONS AG has the market capitalization of 45.14 M, it has increased by 2.48% over the last week.
Yes, you can track MEVIS MEDICAL SOLUTIONS AG financials in yearly and quarterly reports right on TradingView.
MEVIS MEDICAL SOLUTIONS AG is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
M3V net income for the last half-year is 2.66 M EUR, while the previous report showed 3.09 M EUR of net income which accounts for −13.89% change. Track more MEVIS MEDICAL SOLUTIONS AG financial stats to get the full picture.
Yes, M3V dividends are paid annually. The last dividend per share was 0.95 EUR. As of today, Dividend Yield (TTM)% is 3.83%. Tracking MEVIS MEDICAL SOLUTIONS AG dividends might help you take more informed decisions.
MEVIS MEDICAL SOLUTIONS AG dividend yield was 3.35% in 2023, and payout ratio reached 35.15%. The year before the numbers were 2.78% and 22.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 114.00 employees. See our rating of the largest employees — is MEVIS MEDICAL SOLUTIONS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEVIS MEDICAL SOLUTIONS AG EBITDA is 4.38 M EUR, and current EBITDA margin is 28.12%. See more stats in MEVIS MEDICAL SOLUTIONS AG financial statements.
Like other stocks, M3V shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEVIS MEDICAL SOLUTIONS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEVIS MEDICAL SOLUTIONS AG technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEVIS MEDICAL SOLUTIONS AG stock shows the sell signal. See more of MEVIS MEDICAL SOLUTIONS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.